Severe Euglycemic Diabetic Ketoacidosis After Semaglutide-Associated Poor Intake Despite Empagliflozin Discontinuation: A Case Report.

International medical case reports journal

Cardiovascular Risk in SELECT-Eligible MI Patients With Overweight or Obesity: The Western Denmark Heart Registry.

JACC. Advances

Preconception incretin therapy reduces pregnancy and cardiometabolic outcomes in polycystic ovary syndrome.

The Journal of clinical endocrinology and metabolism

Tirzepatide-induced pneumatosis intestinalis: a rare but clinically significant gastrointestinal adverse effect.

American journal of clinical pathology

Comparison of cardiometabolic benefits and tolerability in patients on sustained low doses of semaglutide or tirzepatide.

Biology methods & protocols

Current review of glucagon-like peptide 1 receptor agonists and risk of nonarteritic anterior ischemic optic neuropathy.

Journal of the Endocrine Society

Weight Management in Obesity-Associated Sleep-Disordered Breathing: Mechanisms, Clinical Management, and Emerging Therapies.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Short-term clinical efficacy and recorded adverse events of semaglutide combined with dapagliflozin in patients with type 2 diabetes mellitus and chronic kidney disease.

Medicine

TB 500 is the only peptide that stimulates the migration of repair cells to damaged tissue through a mechanism no other compound replicates. let that sink in. when you injure a muscle, tendon, or ligament, this peptide tells your repair cells exactly where the damage is and

Half-life is one of the most overlooked numbers in peptides. If you don’t understand half-life, you don’t really understand what your dosing schedule is doing. WHAT HALF LIFE MEANS Half-life is the time it takes for the amount of a compound in your body to drop by 50%. After

where does the needle actually go? BPC-157 in the thigh? retatrutide in the glute? GHK-Cu in the love handle? tirzepatide in the belly? semaglutide in the arm? this guide covers all five spots, with the skin and fat drawn to scale for each: https://t.co/Uq6caW0dlA

don't get your reconstitution wrong! BPC-157, semaglutide, tirzepatide or retatrutide from a vial: a wrong draw is a wrong dose, and it repeats with every pin until the vial is empty. check it once, before the first one: https://t.co/uGvr0FbhGj

About 1 in 10 U.S. adults takes GLP-1s for weight loss but no one is sure what's inside. We tested one of the most popular Ro Zepbound: - 102.7% of its labeled tirzepatide amount - Matched the identity reference standard - No detected arsenic, cadmium, lead or mercury Zepbound https://t.co/q74ZhD7N0Z

🔔 Two interesting no placebo trials getting under way, one for Boehringer-Ingelheim’s survodutide (GLP-1/GCG) and another for Pfizer’s berobenatide (GLP-1). 1️⃣ SYNCHRONIZE-START: A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have https://t.co/IZRZlIjXdh

RT @vedichi_: don't get your reconstitution wrong! BPC-157, semaglutide, tirzepatide or retatrutide from a vial: a wrong draw is a wrong d…

RT @vedichi_: don't get your reconstitution wrong! BPC-157, semaglutide, tirzepatide or retatrutide from a vial: a wrong draw is a wrong d…